Enterovirus Infections
14
1
3
8
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
14.3%
2 terminated out of 14 trials
80.0%
-6.5% vs benchmark
14%
2 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (14)
Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
Molecular Epidemiology of Enteroviruses Detected at the Virology Laboratory of Brest University Hospital During the Period 2018-2024: Retrospective Analysis of an Atypical Meningitis Epidemic in 2024 (BrEcho9Men)
Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens
A Study to Evaluate the Efficacy, Immunogenicity and Safety of an EV71 Vaccine in Healthy Infants and Children
Surveillance of HFMD in Pediatric Outpatients
Detection of Enterovirus Genotypes by CRISPR Technology
Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vaccine
First-in-human Clinical Trial Evaluating CUR-N399 in Healthy Volunteers.
A Study to Evaluate the Immunogenicity and Safety of EV71 Vaccine in Pediatric Subjects
Diabetes Virus Detection Project, Intervention With GAD-alum
A Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine in Pediatric Subjects Aged 3 to 6 Years and 6 to 35 Months Old
A Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants
Urinary Excretion of Enteroviruses From Children With a Presumed Enteroviral Infection